Publish Research That Defeats Antibiotic Resistance
The International Journal of Antibiotic Research (IJANR) invites original research, reviews, and clinical studies addressing antimicrobial resistance, antibiotic discovery, and stewardship. We welcome work across microbiology, pharmacology, genomics, diagnostics, and public health that delivers practical solutions for resistant infections and global antimicrobial challenges. Submissions that integrate laboratory findings with clinical outcomes or policy impact are especially encouraged. Priority is given to studies with clear stewardship implications and robust datasets.
Priority Topics
- Novel antibiotics and therapeutic targets
- Resistance mechanisms and gene transfer
- Rapid diagnostics and susceptibility testing
- Stewardship programs and prescribing policy
- One Health and environmental resistance
High Impact Publishing for Antimicrobial Science
Specialist Peer Review
Expert reviewers in microbiology, infectious disease, and pharmacology evaluate rigor, clinical relevance, and translational impact.
Rapid Decisions
Timely editorial processing supports urgent resistance findings and accelerates dissemination of actionable evidence.
Global Visibility
Open access ensures discovery by researchers and practitioners worldwide, improving citations and policy uptake.
Translational Focus
We prioritize studies that connect laboratory discovery with clinical outcomes, diagnostics, and stewardship practice.
Data Transparency
Clear data and code availability statements promote reproducibility and strengthen the antimicrobial evidence base.
Ethics and Integrity
Similarity screening and ethical review protect the integrity of published findings and safeguard public trust.
Topics We Are Actively Seeking
Article Types
We accept original research, systematic reviews, meta analyses, short communications, clinical studies, surveillance reports, and methodological advances in antibiotic research.
Special Issues
Propose special issues on emerging resistance threats, novel therapeutic classes, stewardship innovations, or outbreak investigations with global relevance.
Fast and Fair Review
Initial editorial checks focus on scope, ethics, and data integrity. Peer review evaluates methodological rigor and clinical significance.
Author Support
Clear submission guidance, transparent APCs, and responsive editorial communication help authors move from submission to publication efficiently.
Priority Pathogens
We welcome studies on priority pathogens including carbapenem resistant Gram negative bacilli, MRSA, VRE, and emerging fungal threats. Clearly describe resistance profiles, diagnostic methods, and clinical implications.
Stewardship Implementation
Manuscripts that evaluate stewardship interventions, prescribing audits, diagnostic stewardship, or antimicrobial utilization metrics are strongly encouraged, especially studies linked to patient outcomes.
Diagnostics and Surveillance
We seek innovations in rapid susceptibility testing, genomic surveillance, and outbreak monitoring that improve early detection and response to resistance threats.
Alternative Therapeutics
Research on bacteriophages, antimicrobial peptides, immunotherapies, and novel delivery systems is welcome when supported by rigorous mechanistic or clinical evidence.
Review Timeline
Our editorial team aims to provide initial decisions within 21 days. Clear reporting and complete submissions help reviewers focus on scientific quality.
Ethics and Transparency
All studies must include ethics approvals, consent statements when appropriate, and conflict of interest disclosures. Transparency strengthens trust in antimicrobial research.
Data Availability
Provide a data availability statement and share datasets or code when possible. Clear access instructions improve reproducibility and reuse.
Support for Authors
IJANR offers responsive editorial communication and optional language editing guidance to help authors present complex findings clearly.
Interdisciplinary Studies
We encourage studies that combine microbiology, pharmacology, bioinformatics, and clinical practice. Integrative approaches that link laboratory discovery with patient outcomes are especially valuable.
Early Career Authors
IJANR supports early career researchers through clear guidance and constructive review. Transparent reporting and well organized methods strengthen submissions at all career stages.
Reproducibility Focus
Provide complete methodological detail, data availability statements, and reporting standards so your work can be verified and reused by the antimicrobial research community.
Policy and Practice Impact
Studies that inform stewardship policy, infection control, or treatment guidelines are prioritized. Highlight how results can be applied in real world settings.
Submission Tips
Provide a clear statement of novelty, a strong abstract, and concise conclusions that explain clinical or translational impact.
Method Transparency
Detailed methods, data availability, and reporting standards improve review efficiency and increase trust in resistance findings.
Formatting Readiness
Follow author instructions for structure, references, and reporting standards to speed review and improve clarity.
Global Relevance
Highlight how findings relate to regional resistance burdens and offer implications for stewardship or policy.
Clinical Translational Links
Explain how laboratory findings inform clinical decision making, stewardship, or treatment outcomes to strengthen translational relevance.
Clear Limitations
Summarize limitations and future directions so readers can interpret results in context and build on your work.
Regional Evidence
We welcome studies that provide regional resistance data and highlight practical interventions in diverse settings.
Negative Results
Well designed studies with negative or null findings are encouraged when they inform practice or future research.
Antibiotic resistance is a global emergency. IJANR helps researchers share evidence that informs clinical practice, stewardship, and policy decisions worldwide.
Submit Your Manuscript Today
Choose ManuscriptZone for full submission management or use the simple submission form for a faster start. For questions, contact [email protected] and include your manuscript type for quicker routing. We welcome presubmission questions on scope and fit. Submissions are accepted year round, including replication studies and negative results. Please include a concise cover letter.
